<SEC-DOCUMENT>0001493152-25-019362.txt : 20251024
<SEC-HEADER>0001493152-25-019362.hdr.sgml : 20251024
<ACCEPTANCE-DATETIME>20251024172215
ACCESSION NUMBER:		0001493152-25-019362
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251024
DATE AS OF CHANGE:		20251024

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vivos Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001716166
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				813224056
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-284834
		FILM NUMBER:		251416996

	BUSINESS ADDRESS:	
		STREET 1:		7921 SOUTHPARK PLAZA,
		STREET 2:		SUITE 210
		CITY:			LITTLETON
		STATE:			CO
		ZIP:			80120
		BUSINESS PHONE:		(866)908-4867

	MAIL ADDRESS:	
		STREET 1:		7921 SOUTHPARK PLAZA,
		STREET 2:		SUITE 210
		CITY:			LITTLETON
		STATE:			CO
		ZIP:			80120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Vivos BioTechnologies, Inc.
		DATE OF NAME CHANGE:	20170901
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>form424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS
SUPPLEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(To
Prospectus Supplement Dated September 12, 2025)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
Pursuant to Rule 424(b)(5)<BR>
Registration No. 333-284834</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="logo_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to $3,583,686</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement amends and supplements the information in the prospectus, dated September 10, 2025, filed as a part of our registration
statement on Form S-3 (File No. 333-284834), or the Registration Statement, as supplemented by our prospectus supplement, dated September
12, 2025 (collectively the &ldquo;Prior Prospectus&rdquo;), relating to the offering, issuance and sale by us of our common stock from
time to time that may be issued and sold under the at the market offering agreement, dated February 14, 2025 (the &ldquo;Sales Agreement&rdquo;),
by and between us and H.C. Wainwright &amp; Co., LLC (&ldquo;Wainwright&rdquo;), as sales agent. This prospectus supplement should be
read in conjunction with the Prior Prospectus, and is qualified by reference thereto, except to the extent that the information herein
amends or supersedes the information contained in the Prior Prospectuses. This prospectus supplement is not complete without, and may
only be delivered or utilized in connection with, the Prior Prospectus, and any future amendments or supplements thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are filing this prospectus supplement to amend the Prior Prospectus to update the maximum amount of shares we are eligible to sell under
our Registration Statement pursuant to General Instruction I.B.6 of Form S-3. As a result of these limitations and the current public
float of our common stock, and in accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock
having an aggregate offering price of up to $3,583,686 from time to time through Wainwright, which does not include the shares of common
stock having an aggregate sales price of approximately $4,605,773 that were sold pursuant to the Prior Prospectus to date. In
the event that we may sell additional amounts under the Sales Agreement in accordance with General Instruction I.B.6, we will file another
prospectus supplement prior to making such additional sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus supplement, the aggregate market value of our outstanding common stock held by non-affiliates, or the
public float, was approximately $35,068,378, which was calculated based on 7,477,266 shares of our outstanding common stock held
by non-affiliates at a price of $4.69 per share, the closing price of our common stock on the Nasdaq Capital Market on August 26, 2025.
During the 12 calendar months prior to, and including, the date of this prospectus supplement, we sold securities with an aggregate market
value of approximately $8,105,774 pursuant to General Instruction I.B.6 of Form S-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on the Nasdaq Capital Market under the symbol &ldquo;VVOS.&rdquo; On October 23, 2025, the last reported
sale price of our common stock on the Nasdaq Capital Market was $2.97 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Investing
in our common stock is speculative involves a high degree of risk</I>. See &ldquo;Risk Factors,&rdquo; beginning on page S-10 of the
Prior Prospectus, as well as the risks discussed under similar headings in the documents incorporated by reference in this prospectus
supplement and the Prior Prospectus (as they may be amended, updated or modified periodically in our reports filed with the Securities
and Exchange Commission), for a discussion of the factors you should carefully consider before deciding to purchase our securities</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus supplement or the accompanying Prior Prospectus is truthful or complete. Any representation to the contrary is a criminal
offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 16pt"><B>H.C.
Wainwright &amp; Co.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>The
date of this prospectus supplement is October 24, 2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$ / # 2(  A$! Q$!_\0
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MOQ1I?BFQ^TZ?*=R\2POP\9]Q_6K>L:-8:]8/9:C;K-"PZ$<J?4'L:\&E6_\
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M3T-Y*1^E=M?:=9ZG:/:WMO'<6\GWHY!D&@#D=&^*?AO5(E^TW7]GSD?-%<C
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!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
